| RBP4 quartiles |  | |||
---|---|---|---|---|---|
 | 1 | 2 | 3 | 4 | P 2 |
Metabolic syndrome (no. cases) | 131 | 171 | 193 | 251 | Â |
Model 13 | 1.00 | 1.65 (1.29, 1.99) | 2.28 (1.76, 2.89) | 3.84 (3.12, 4.58) | <0.001 |
Model 24 | 1.00 | 1.61 (1.26, 1.97) | 2.15 (1.65, 2.73) | 3.46 (2.87, 4.42) | <0.001 |
Model 35 | 1.00 | 1.53 (1.21, 1.92) | 2.04 (1.58, 2.47) | 2.68 (1.95, 3.67) | <0.001 |
Central obesity | 183 | 204 | 214 | 331 | Â |
Model 1 | 1.00 | 1.23 (1.02, 1.51) | 1.42 (1.08, 1.75) | 1.87 (1.48, 2.36) | <0.001 |
Model 2 | 1.00 | 1.01 (0.74, 1.32) | 0.97 (0.67, 1.28) | 0.92 (0.66, 1.35) | 0.69 |
Model 3 | 1.00 | 0.94 (0.66, 1.29) | 0.87 (0.65, 1.25) | 0.81 (0.61, 1.14) | 0.23 |
Hypertriglyceridemia | 46 | 77 | 112 | 197 | Â |
Model 1 | 1.00 | 2.13 (1.64, 2.87) | 3.45 (2.61, 4.49) | 6.75 (5.28, 8.96) | <0.001 |
Model 2 | 1.00 | 2.06 (1.52, 2.83) | 3.26 (2.47, 4.33) | 5.92 (4.47, 8.02) | <0.001 |
Model 3 | 1.00 | 1.97 (1.46, 2.68) | 3.01 (2.16, 4.08) | 5.03 (3.59, 7.45) | <0.001 |
Reduced HDL cholesterol | 154 | 171 | 177 | 186 | Â |
Model 1 | 1.00 | 1.24 (1.05, 1.51) | 1.38 (1.15, 1.67) | 1.76 (1.26, 2.17) | <0.001 |
Model 2 | 1.00 | 1.15 (0.97, 1.39) | 1.27 (1.04, 1.58) | 1.58 (1.17, 1.84) | <0.001 |
Model 3 | 1.00 | 1.07 (0.90, 1.26) | 1.18 (0.96, 1.51) | 1.42 (1.11, 1.68) | <0.001 |
Elevated blood pressure | 161 | 116 | 117 | 132 | Â |
Model 1 | 1.00 | 0.93 (0.81, 1.17) | 1.02 (0.84, 1.33) | 1.10 (0.95, 1.44) | 0.32 |
Model 2 | 1.00 | 0.87 (0.76, 1.15) | 0.97 (0.81, 1.24) | 1.02 (0.84, 1.29) | 0.11 |
Model 3 | 1.00 | 0.83 (0.68, 1.10) | 0.76 (0.62, 1.02) | 0.73 (0.61, 1.16) | 0.08 |
Hyperglycemia | 135 | 167 | 188 | 245 | Â |
Model 1 | 1.00 | 1.57 (1.26, 1.95) | 1.72 (1.35, 2.14) | 3.13 (2.44, 3.93) | <0.001 |
Model 2 | 1.00 | 1.50 (1.17, 1.84) | 1.67 (1.31, 1.96) | 2.74 (2.15, 3.36) | <0.001 |
Model 3 | 1.00 | 1.42 (1.06, 1.75) | 1.52 (1.23, 1.75) | 2.32 (1.85, 2.91) | <0.001 |